ReviewLasers in medical science2026
Strategic selection of multi-parametric laser settings and clinical endpoints in dermatology: an engineering-to-clinical review.
Review in Lasers in medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Selective photothermolysis, which enables precise targeting of melanin, hemoglobin, and water, is the foundation for modern dermatologic laser therapy. This review bridges laser physics with clinical practice by organizing systems on the basis of spectral domain and indication: Q-switched and picosecond lasers for tattoos and lentigines; pulsed-dye and long-pulsed neodymium-doped yttrium aluminum garnet (Nd:YAG) lasers for vascular lesions; alexandrite and diode lasers for hair removal; and fractional ablative (CO₂, erbium-doped yttrium aluminum garnet [Er:YAG]) and non-ablative platforms for scar revision and rejuvenation. Unlike conventional textbook reviews that merely list device specifications, we specifically define how to dynamically adjust comprehensive parameters not just wavelength, but also pulse duration, fluence, and spot size-in direct response to immediate clinical endpoints observed during treatment. We delineated the selection of parameters-wavelength, pulse duration, fluence, and spot size-in relation to the Fitzpatrick skin type, focusing on cooling, treatment endpoints, and recovery. Current evidence regarding efficacy, recurrence, and complications has been synthesized, and the device parameters have been linked to thermal relaxation and Arrhenius injury kinetics to inform safer evidence-based algorithms and multimodal treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.